Exabis Library
Welcome to the e-CCO Library!
P567: Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activity
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P567: How can we predict the development of antibodies to infliximab in Crohn's disease?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P567: Long-term outcome of perianal fistulae treated with anti-TNFα therapy in a cohort of Saudi patients with Crohn’s disease based on Parks classification
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P567: Pharmacist-managed immunomodulator clinic in titration and monitoring of immunosuppressants in Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P567: Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P568 An open-label, multicenter, phase ib, pharmacokinetic (pk) and safety study of a fimh blocker, Sibofimloc (TAK-018/EB8018), in patients with Crohn’s disease (CD)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P568: Bowel ultrasonography is useful to evaluate disease activity in ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P568: Does infliximab therapy increase incidence of tuberculosis in patients with inflammatory bowel disease in an endemic area: a nationwide study from China
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P568: Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn’s disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P568: Impact of Biologics and Small Molecules for Inflammatory Bowel Disease on COVID-19 Related Hospitalization: A Systematic Review and Meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P568: Patients with ulcerative colitis after pouch surgery are at risk for low spinal bone mineral density: a cross sectional study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P568: The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P569 The role of multidrug-resistant infections in IBD patients undergoing surgery
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P569: A national, retrospective, observational study on the use of 5-aminosalicylates (5-ASA) in Crohn’s disease (CD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P569: Can thiopurines prevent crohn's disease endoscopic postoperative recurrence in at risk patients?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P569: Fecal Microbiome Transplantation for Recurrent C. difficile Colitis: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P569: Online education significantly improved gastroenterologists' knowledge of management strategies and treatment options for ulcerative colitis.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P569: Outcomes of IBD patients treated with infliximab: The impact of therapeutic drug monitoring in real-life clinical practice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P569: Sequential rescue treatments in steroid refractory ulcerative colitis: two-year follow-up
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P570 The burden of anaemia remains significant over time in patients with inflammatory bowel disease at a tertiary referral centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM